MRNA · Moderna

S&P 500 #406 · Nasdaq

Risiko 8/10 · High-Risk Biotech Rebound · $55.80 ▲ 0.31%

Kennzahlen

• Price $55.80
• Market cap $22.1B
• P/E (ttm) n/a
• Div yield none
• 52-wk range $22.28 – $85.60
• Index rank #406 / —

Wichtigste Risiken

• Post-COVID mRNA revenue collapse (Revenue/Solvency) — EXTREME
• Pipeline binary event risk (Shareholders) — EXTREME
• Cash burn ($3.2B net loss TTM) (Balance Sheet) — HIGH
• Vaccine hesitancy and regulatory risk (Commercialization) — HIGH

Fazit

mRNA pioneer near 52-week high on pipeline momentum; still burning $3B/yr with no near-term path to profitability.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.